249 related articles for article (PubMed ID: 27821098)
1. Frequency of Her2/neu expression in colorectal adenocarcinoma: a study from developing South Asian Country.
Shabbir A; Mirza T; Khalid AB; Qureshi MA; Asim SA
BMC Cancer; 2016 Nov; 16(1):855. PubMed ID: 27821098
[TBL] [Abstract][Full Text] [Related]
2. Gastric adenocarcinoma expressing human epidermal growth factor receptor in South Asian population.
Shabbir A; Qureshi MA; Khalid AB; Mirza T; Shaikh A; Hasan SM
Saudi J Gastroenterol; 2018; 24(5):289-293. PubMed ID: 29806596
[TBL] [Abstract][Full Text] [Related]
3. Frequency of HER2/neu overexpression in adenocarcinoma of the gastrointestinal system.
Farzand S; Siddique T; Saba K; Bukhari MH
World J Gastroenterol; 2014 May; 20(19):5889-96. PubMed ID: 24914350
[TBL] [Abstract][Full Text] [Related]
4. Clinicopathologic significance of EGFR and Her-2/neu in colorectal adenocarcinomas.
Kountourakis P; Pavlakis K; Psyrri A; Rontogianni D; Xiros N; Patsouris E; Pectasides D; Economopoulos T
Cancer J; 2006; 12(3):229-36. PubMed ID: 16803682
[TBL] [Abstract][Full Text] [Related]
5. Is overexpression of HER-2 a predictor of prognosis in colorectal cancer?
Kavanagh DO; Chambers G; O'Grady L; Barry KM; Waldron RP; Bennani F; Eustace PW; Tobbia I
BMC Cancer; 2009 Jan; 9():1. PubMed ID: 19118499
[TBL] [Abstract][Full Text] [Related]
6. Expression of Human Epidermal Growth Factor Receptor (Her 2/neu) and Proliferative Marker Ki-67: Association with Clinicopathological Parameters in Gallbladder Carcinoma.
Pujani M; Makker I; Makker A; Jetley S; Goel MM; Jetley S
Asian Pac J Cancer Prev; 2016; 17(8):3903-9. PubMed ID: 27644637
[TBL] [Abstract][Full Text] [Related]
7. Clinicopathological relevance of HER2/neu and a related gene-protein cubic regression correlation in colorectal adenocarcinomas in Taiwan.
Li JW; Chuang TC; Yang AH; Hsu CK; Kao MC
Int J Oncol; 2005 Apr; 26(4):933-43. PubMed ID: 15753987
[TBL] [Abstract][Full Text] [Related]
8. Her-2/neu over-expression correlates with more advanced disease in Iranian colorectal cancer patients.
Tavangar SM; Shariftabrizi A; Soroush AR
Med Sci Monit; 2005 Mar; 11(3):CR123-6. PubMed ID: 15735564
[TBL] [Abstract][Full Text] [Related]
9. Expression of
Pandey I; Misra V; Pandey AT; Verma A
Indian J Pathol Microbiol; 2022; 65(1):35-41. PubMed ID: 35074963
[TBL] [Abstract][Full Text] [Related]
10. The prognostic value of invariant chain (Ii) and Her-2/neu expression in curatively resected colorectal cancer.
Rossi HA; Liu Q; Banner B; Hsieh CC; Savas L; Savarese D
Cancer J; 2002; 8(3):268-75. PubMed ID: 12074327
[TBL] [Abstract][Full Text] [Related]
11. Association between Her2/neu status in colorectal carcinoma and clinicopathological features: a retrospective study using whole - tissue sections.
Kılıçarslan A; Dogan HT; Süngü N; Dogan M; Yalcin A; Dede DŞ
Pol J Pathol; 2018; 69(2):143-149. PubMed ID: 30351861
[TBL] [Abstract][Full Text] [Related]
12. HER 2/neu protein expression in colorectal cancer.
Schuell B; Gruenberger T; Scheithauer W; Zielinski Ch; Wrba F
BMC Cancer; 2006 May; 6():123. PubMed ID: 16681853
[TBL] [Abstract][Full Text] [Related]
13. Clinical role of HER-2/neu expression in colorectal cancer.
Pappas A; Lagoudianakis E; Seretis C; Tsiambas E; Koronakis N; Toutouzas K; Katergiannakis V; Manouras A
J BUON; 2013; 18(1):98-104. PubMed ID: 23613394
[TBL] [Abstract][Full Text] [Related]
14. HER-2/neu overexpression is an independent prognostic factor in colorectal cancer.
Park DI; Kang MS; Oh SJ; Kim HJ; Cho YK; Sohn CI; Jeon WK; Kim BI; Han WK; Kim H; Ryu SH; Sepulveda AR
Int J Colorectal Dis; 2007 May; 22(5):491-7. PubMed ID: 16947041
[TBL] [Abstract][Full Text] [Related]
15. Her-2/neu, p-53, and their coexpression in osteosarcoma.
Bakhshi S; Gupta A; Sharma MC; Khan SA; Rastogi S
J Pediatr Hematol Oncol; 2009 Apr; 31(4):245-51. PubMed ID: 19346874
[TBL] [Abstract][Full Text] [Related]
16. Alteration in key oncoprotein expression in gastric adenocarcinoma - An immunohistochemical study.
Jain P; Wadhwa N; Diwaker P; Joshi MK; Mishra K
J Cancer Res Ther; 2023 Apr; 19(Supplement):S0. PubMed ID: 37147954
[TBL] [Abstract][Full Text] [Related]
17. The expression of p185(HER-2/neu) correlates with the stage of disease and survival in colorectal cancer.
Kapitanović S; Radosević S; Kapitanović M; Andelinović S; Ferencić Z; Tavassoli M; Primorać D; Sonicki Z; Spaventi S; Pavelic K; Spaventi R
Gastroenterology; 1997 Apr; 112(4):1103-13. PubMed ID: 9097992
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of HER-2/neu overexpression in gastric carcinoma using a tissue microarray.
Rakhshani N; Kalantari E; Bakhti H; Sohrabi MR; Mehrazma M
Asian Pac J Cancer Prev; 2014; 15(18):7597-602. PubMed ID: 25292034
[TBL] [Abstract][Full Text] [Related]
19. Heterogenous high-level HER-2 amplification in a small subset of colorectal cancers.
Marx AH; Burandt EC; Choschzick M; Simon R; Yekebas E; Kaifi JT; Mirlacher M; Atanackovic D; Bokemeyer C; Fiedler W; Terracciano L; Sauter G; Izbicki JR
Hum Pathol; 2010 Nov; 41(11):1577-85. PubMed ID: 20656317
[TBL] [Abstract][Full Text] [Related]
20. Immunohistochemical detection of Her-2/neu overexpression in breast carcinoma in Nigerians: a 5-year retrospective study.
Ugiagbe EE; Olu-Eddo AN; Obaseki DE
Niger J Clin Pract; 2011; 14(3):332-7. PubMed ID: 22037080
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]